Table 3.
StableULN NSE(n = 29) | IncreasedULN NSE(n = 14) | P value | |
---|---|---|---|
min. ACT, s | 251 (68.5) | 269 (53.75) | 0.16 |
min. DBP, mmHg | 50 (7.5) | 50 (15) | 0.41 |
min. SBP, mmHg | 80 (12.5) | 80 (31.25) | 0.85 |
max. DBP, mmHg | 80 (17.5) | 80 (1.25) | 0.64 |
max. SBP, mmHg | 140 (40) | 130 (37.5) | 0.57 |
Total procedural time, min | 150 (57.5) | 150 (65) | 0.68 |
Left atrial access time, min | 20 (12.5) | 15 (7.5) | 0.16 |
Patients with preprocedural atrial fibrillation | 5 (17%) | 1 (7%) | 0.64 |
Patients requiring electrical cardioversion | 5 (17%) | 6 (42%) | 0.13 |
min. ACT of <250 s | 13 (44%) | 3 (21%) | 0.14 |
Values are given as n (%) or median (interquartile range).
NSE, neuron-specific enolase; ULN, upper limit of normal; ACT, activated clotting time; DBP, diastolic blood pressure; max., maximal; min., minimal; SBP, systolic blood pressure